Enactment of abortion restrictions in a growing number of states could have a chilling effect on therapy regimens in pregnant women and their desire to participate in clinical trials.
Women with MS who stop taking natalizumab during pregnancy are at a significantly increased risk of relapse-related disability up to 1 year after delivery, new research shows.
The Isotretinoin Products Manufacturers Group has "created a new tool within the system to help resolve account access for some user groups without using the call center."
Die Einnahme von Medikamenten während der Schwangerschaft ist oft eine heikle Sache. Schnell steht die Gesundheit des Kindes auf dem Spiel. Experten der Barmer fordern daher, die Arzneimittelgabe besser zu überprüfen.